drugset

drugset / Trial / NCT00372372

The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment

NCT00372372 ↗

Phase 4 Completed 120 enrolled Tuen Mun Hospital

RandomizedParallel-groupDouble-blindTreatment

Summary

The efficacy of risedronate in prevention of bone loss in patients receiving high dose corticosteroid treatment

Timeline

Start: 2004-01
Primary completion: —
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Risedronate	Small molecule	—	—

Indications